Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertension, Essential Hypertension”

721 trials

Showing 20 of 721 results

Early research (Phase 1)Study completedNCT06884085
What this trial is testing

Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

Who this might be right for
Primary Hypertension
Addpharma Inc. 70
Not applicableStudy completedNCT02385721
What this trial is testing

Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 601
Not applicableUnknownNCT04463121
What this trial is testing

Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)

Who this might be right for
BradycardiaHypertension, Systolic
BackBeat Medical Inc 30
Large-scale testing (Phase 3)Study completedNCT01701726
What this trial is testing

Effect of Acupuncture on Patients With Mild Hypertension

Who this might be right for
Essential Hypertension
Chengdu University of Traditional Chinese Medicine 400
Post-approval studies (Phase 4)Study completedNCT00185068
What this trial is testing

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

Who this might be right for
Hypertension
Daiichi Sankyo 110
Large-scale testing (Phase 3)Study completedNCT06165250
What this trial is testing

Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C

Who this might be right for
Essential HypertensionPrimary Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd 156
Post-approval studies (Phase 4)Study completedNCT00931710
What this trial is testing

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

Who this might be right for
Stage 2 Systolic Hypertension
Novartis 488
Large-scale testing (Phase 3)Study completedNCT00940680
What this trial is testing

Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

Who this might be right for
Hypertension
Hanmi Pharmaceutical Company Limited 142
Not applicableUnknownNCT04565548
What this trial is testing

Hypertension Treatment Adherence Improving Trial

Who this might be right for
Hypertension,Essential
The Hong Kong Polytechnic University 148
Post-approval studies (Phase 4)Study completedNCT00333489
What this trial is testing

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Who this might be right for
Hypertension
Novartis 551
Large-scale testing (Phase 3)Study completedNCT01672476
What this trial is testing

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 293
Large-scale testing (Phase 3)Study completedNCT05362110
What this trial is testing

Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension

Who this might be right for
Hypertension
Hanmi Pharmaceutical Company Limited 361
Large-scale testing (Phase 3)Study completedNCT05820880
What this trial is testing

Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

Who this might be right for
Hypertension
Institut de Recherches Internationales Servier 532
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Post-approval studies (Phase 4)Study completedNCT02031861
What this trial is testing

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Shyndec Pharmaceutical Co., Ltd. 38
Large-scale testing (Phase 3)Study completedNCT00706134
What this trial is testing

Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study

Who this might be right for
Hypertension
Novartis 756
Post-approval studies (Phase 4)Study completedNCT03276598
What this trial is testing

A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

Who this might be right for
HypertensionPharmacogenetics
Helsinki University Central Hospital 233
Not applicableStudy completedNCT04303689
What this trial is testing

Repurposing Colchicine to Improve Vascular Function in Hypertension

Who this might be right for
Essential Hypertension
University of Copenhagen 31
Large-scale testing (Phase 3)Study completedNCT00441350
What this trial is testing

Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

Who this might be right for
Hypertension
Menarini Group 1,004
Early research (Phase 1)Study completedNCT00662610
What this trial is testing

Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure

Who this might be right for
OsteoarthritisHypertension
NicOx 120
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation